MedTrace Logo

Safety of Nitroglycerin for Field Treatment of STEMI

NCT02407002 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 940

Last updated 2017-08-25

No results posted yet for this study

Summary

The purpose of this study is to quantify the risk of hypotension due to field treatment with nitroglycerin in patients with ST-elevation myocardial infarction, particularly right ventricular infarcts, and secondarily to evaluate the benefit to pain relief..

Conditions

Sponsors & Collaborators

  • University of California, Los Angeles

    collaborator OTHER

  • Cedars-Sinai Medical Center

    collaborator OTHER

  • Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

    lead OTHER

Principal Investigators

  • Nichole Bosson, MD, MPH · Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-12-31
Completion
2017-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02407002 on ClinicalTrials.gov